Skip links

Case Study

Even Unicorns Get a Boost from Data Analytics

Machine learning gives a FinTech unicorn a marketing makeover.

Successful marketing teams need efficient data matching and pairing processes to succeed. This was a big challenge for one of our FinTech clients, who was aggregating data from various sources and running advanced analytics models on local machines.

Altimetrik created a machine-learning model that provided better data in a timely matter, ultimately making our client more agile and nimble with more robust data, deeper insights, faster ability to take action, and better feedback loops.

  • Increased Revenue by More Than £1,000,000+
  • Reduced New Model Development Timelines by 70%
  • Improved Efficiency of Direct Marketing Performance
  • Higher Incremental Annual Originations

Robust data and analytics are collected seamlessly.

Aggregating data from various sources without a reliable collation mechanism and running advanced analytics models on local machines led to a cumbersome data matching and pairing process for this Fintech marketing team. Building out data models took 6-10 months and even the most basic uses of the data–list management and analysis–were manual, complex, and prone to error.

With a Big Bang approach, a significant amount of money is invested in building a large data lake project. The roadmap planning team knew that it might take months or years to realize any true business insights or results. The Altimetrik team took a lean approach–creating a machine-learning model with just enough data to allow the team to seed the data lake while further enrichment would enable the build-out of additional models.

Elements of the makeover included:

  • Building a cloud-based (AWS) data lake for ingesting the data from various sources
  • Crafting a resilient architecture from the ground up
  • Designing the data pipeline to simplify the future addition of new data sources
  • Employing a well-conceived battery of Agile (Scrum and Kanban) teams who delivered work in line with stringent compliance/audit requirements
  • Using the new data lake to create Machine Learning models

Robust data and deep insights that are relevant to current / near-future business cycles, and better feedback loops provided improved ROI and dramatically increased revenue.

“Decisions – small and large – are made with a combination of analytics drawn from data and augmented by the business experience. Decision-makers now have the ability to gather deep insights and create predictive tools and analytics that drive real business outcomes.”

Jayaprakash Nair

Head, Analytics Coe

Digital Business Methodology

The Growth Code

We give you the DBM Growth Code: A step-by-step guide written by practitioners to help you accelerate digital business.

Latest Insights

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes